| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1048-891X.2004.014508.X |
| P698 | PubMed publication ID | 15361184 |
| P2093 | author name string | Thomas L | |
| Bussières E | |||
| Floquet A | |||
| Picot V | |||
| Avril A | |||
| Macgrogan G | |||
| Paravis P | |||
| Stoeckle E | |||
| Tunon de Lara C | |||
| P433 | issue | 5 | |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 779-787 | |
| P577 | publication date | 2004-09-01 | |
| P1433 | published in | International Journal of Gynecological Cancer | Q15749181 |
| P1476 | title | Number of residual nodules, better than size, defines optimal surgery in advanced epithelial ovarian cancer | |
| P478 | volume | 14 |
| Q36762307 | Computerized System for Staging Peritoneal Surface Malignancies |
| Q24234923 | Optimal primary surgical treatment for advanced epithelial ovarian cancer |
| Q24242510 | Optimal primary surgical treatment for advanced epithelial ovarian cancer |
| Q80070150 | Prognostic factors for complete debulking in advanced ovarian cancer and its impact on survival. An exploratory analysis of a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (A |
| Q44157236 | Progress in survival outcomes in patients with advanced ovarian cancer treated by neo-adjuvant platinum/taxane-based chemotherapy and late interval debulking surgery |
| Q34762831 | Survival impact of complete cytoreduction to no gross residual disease for advanced-stage ovarian cancer: a meta-analysis |
Search more.